Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
AssigneeThe Trustees of the University of Pennsylvania
InventorsJames M Wilson, Guangping Gao, Soumitra Roy
Life of this patent
Estimating the term…
Abstract
A recombinant vector comprises simian adenovirus sequences and a heterologous gene under the control of regulatory sequences. A cell line which expresses simian adenovirus gene(s) is also disclosed. Methods of using the vectors and cell lines are provided.
Claims9
A recombinant adenovirus having an adenovirus capsid comprising an AdPan5 hexon protein having the amino acid sequence of SEQ ID NO:3, said adenovirus having packaged therein a nucleic acid molecule comprising (a) an adenovirus 5′ inverted terminal repeat sequence, (b) a nucleic acid sequence heterologous to AdPan5 encoding a therapeutic or an immunogenic product operably linked to expression control sequences which direct transcription, translation, and/or expression of said product in a cell, and (c) an adenovirus 3′ inverted terminal repeat sequence, wherein the heterologous nucleic acid sequence defined in (b) is located between the 5′ inverted terminal repeat sequence defined in (a) and the 3′ inverted terminal repeat sequence defined in (c).
The recombinant adenovirus according to 1, wherein the nucleic acid molecule further comprises adenoviral genomic sequences which comprises a deletion in the E1 region of the adenovirus genes.
A recombinant adenovirus having an adenovirus capsid comprising an AdPan5 hexon protein having the amino acid sequence of SEQ ID NO:3, an AdPan5 penton protein, and an AdPan5 fiber protein, said adenovirus having packaged therein a nucleic acid molecule comprising (a) an adenovirus 5′ inverted terminal repeat sequence, (b) a nucleic acid sequence heterologous to AdPan5 encoding a therapeutic or an immunogenic product operably linked to expression control sequences which direct transcription, translation, and/or expression thereof in a host cell, and (c) an adenovirus 3′ inverted terminal repeat sequence, wherein the heterologous nucleic acid sequence defined in (b) is located between the 5′ inverted terminal repeat sequence defined in (a) and the 3′ inverted terminal repeat sequence defined in (c).
Dependencies are inferred from the claim text.